Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Michael Camilleri, M.D.

Back to Research Profile

  1. Camilleri M, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil 2009 Dec; 21(12):1256-e117. Epub 2009 Sep 09.
    View PubMed
  2. Camilleri M, Andresen V. Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis 2009 Dec; 41(12):854-62. Epub 2009 Aug 08.
    View PubMed
  3. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther 2009 Nov 03. [Epub ahead of print]
    View PubMed
  4. Manabe N, Cremonini F, Camilleri M, Sandborn WJ, Burton DD. Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers. Aliment Pharmacol Ther 2009 Nov 1; 30(9):930-6. Epub 2009 Aug 12.
    View PubMed
  5. Camilleri M. Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics. Dig Dis Sci 2009 Nov; 54(11):2318-24. Epub 2009 Aug 05.
    View PubMed
  6. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, Burton D, Carlson P, Busciglio IA, Lamsam J, Singh R, Zinsmeister AR. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2009 Oct 29. [Epub ahead of print]
    View PubMed
  7. Papathanasopoulos A, Camilleri M, Carlson PJ, Vella A, Nord SJ, Burton DD, Odunsi ST, Zinsmeister AR. A Preliminary Candidate Genotype-Intermediate Phenotype Study of Satiation and Gastric Motor Function in Obesity. Obesity (Silver Spring) 2009 Oct 29. [Epub ahead of print]
    View PubMed
  8. Camilleri M. Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes? The Con Argument. Clin Gastroenterol Hepatol 2009 Oct 20. [Epub ahead of print]
    View PubMed
  9. Keller J, Andresen V, Wolter J, Layer P, Camilleri M. Influence of clinical parameters on the results of C-13-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil 2009 Oct; 21(10):1039-E83.
    View PubMed
  10. Keller J, Andresen V, Wolter J, Layer P, Camilleri M. Influence of clinical parameters on the results of C-13-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil 2009 Oct; 21(10):1039-E83.
    View PubMed
  11. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther 2009 Sep 24. [Epub ahead of print]
    View PubMed
  12. Revicki DA, Camilleri M, Kuo B, Norton NJ, Murray L, Palsgrove A, Parkman HP. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther 2009 Sep 15; 30(6):670-80.
    View PubMed
  13. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zucchelli M, D'Amato M. Neuropeptide S Receptor Induces Neuropeptide Expression and Associates with Intermediate Phenotypes of Functional Gastrointestinal Disorders. Gastroenterology 2009 Sep 02. [Epub ahead of print]
    View PubMed
  14. Gathaiya N, Locke GR, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil 2009 Sep; 21(9):NIL_12-8.
    View PubMed
  15. Gathaiya N, Locke Iii GR, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil 2009 Sep; 21(9):922-e69. Epub 2009 Jun 02.
    View PubMed
  16. Manini ML, Camilleri M, Goldberg M, Sweetser S, McKinzie S, Burton D, Wong S, Kitt MM, Li YP, Zinsmeister AR. Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil 2009 Aug 18. [Epub ahead of print]
    View PubMed
  17. Camilleri M. Peripheral mechanisms in the control of appetite and related experimental therapies in obesity. Regul Pept 2009 Aug 7; 156(1-3):24-7. Epub 2009 May 03.
    View PubMed
  18. Ravi K, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic Variation of Colonic Motor Functions in Chronic Constipation. Gastroenterology 2009 Aug 04. [Epub ahead of print]
    View PubMed
  19. Karthik R, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic Variation of Colonic Motor Functions in Chronic Constipation. Gastroenterology 2009 Aug 03. [Epub ahead of print]
    View PubMed
  20. Izzo AA, Camilleri M. Cannabinoids in intestinal inflammation and cancer. Pharmacol Res 2009 Aug; 60(2 Special Issue SI):117-25.
    View PubMed
  21. Szarka LA, Camilleri M. Gastric emptying. Clin Gastroenterol Hepatol 2009 Aug; 7(8):823-7. Epub 2009 Apr 24.
    View PubMed
  22. Camilleri M, Nadeau A, Lamsam J, Linker Nord S, Ryks M, Burton D, Sweetser S, Zinsmeister AR, Singh R. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil 2009 Jul 10. [Epub ahead of print]
    View PubMed
  23. Odunsi ST, Camilleri M, Szarka LA, Zinsmeister AR. Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil 2009 Jul; 21(7):706-e38. Epub 2009 Feb 27.
    View PubMed
  24. Camilleri M, Nadeau A, Tremaine WJ, Lamsam J, Burton D, Odunsi S, Sweetser S, Singh R. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009 Jul; 21(7):734-e43. Epub 2009 Mar 13.
    View PubMed
  25. Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, Lurken MS, Schmalz PF, Roeder JL, Linden D, Cima RR, Dozois EJ, Larson DW, Camilleri M, Zinsmeister AR, Pozo MJ, Hicks GA, Farrugia G. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil 2009 Jul; 21(7):746-e46. Epub 2009 Feb 08.
    View PubMed
  26. Camilleri M, Papathanasopoulos A, Odunsi ST. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2009 Jun; 6(6):343-52.
    View PubMed
  27. Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R, Zinsmeister AR. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol 2009 Jun; 296(6):G1299-306. Epub 2009 Apr 02.
    View PubMed
  28. Odunsi ST, Camilleri M. Selected interventions in nuclear medicine: gastrointestinal motor functions. Semin Nucl Med 2009 May; 39(3):186-94.
    View PubMed
  29. Camilleri M. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut? J Pediatr Gastroenterol Nutr 2009 Apr; 48 Suppl 2:S46-8.
    View PubMed
  30. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Pharmacogenetics of low dose clonidine in irritable bowel syndrome. Neurogastroenterol Motil 2009 Apr; 21(4):399-410.
    View PubMed
  31. Odunsi ST, Camilleri M, Bharucha AE, Papathanasopoulos A, Busciglio I, Burton D, Zinsmeister AR. Reproducibility and Performance Characteristics of Colonic Compliance, Tone, and Sensory Tests in Healthy Humans. Dig Dis Sci 2009 Mar 17. [Epub ahead of print]
    View PubMed
  32. Camilleri M. Is Adequate Relief Fatally Flawed or Adequate as an End Point in Irritable Bowel Syndrome? Am J Gastroenterol 2009 Mar 17. [Epub ahead of print]
    View PubMed
  33. Floyd BN, Camilleri M, Busciglio I, Sweetser S, Burton D, Wong GY, Kell S, Khanna S, Hwang S, Zinsmeister AR. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers. Neurogastroenterol Motil 2009 Mar; 21(3):281-90. Epub 2008 Sep 23.
    View PubMed
  34. Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf) 2009 Mar; 70(3):415-20. Epub 2008 Aug 22.
    View PubMed
  35. Szarka LA, Camilleri M. Methods for measurement of gastric motility. Am J Physiol Gastrointest Liver Physiol 2009 Mar; 296(3):G461-75. Epub 2009 Jan 15.
    View PubMed
  36. Camilleri M, Toouli J, Herrera MF, Kow L, Pantoja JP, Billington CJ, Tweden KS, Wilson RR, Moody FG. Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surg Obes Relat Dis 2009 Mar-Apr; 5(2):224-9; discussion 229-30. Epub 2008 Sep 12.
    View PubMed
  37. Camilleri M. The stomach in diabetes: from villain to ally. Clin Gastroenterol Hepatol 2009 Mar; 7(3):285-7. Epub 2008 Nov 06.
    View PubMed
  38. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zaki EA, Boles RG. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol 2009 Mar; 296(3):G510-6. Epub 2009 Jan 15.
    View PubMed
  39. Manini ML, Burton DD, Meixner DD, Eckert DJ, Callstrom M, Schmit G, El-Youssef M, Camilleri M. Feasibility and application of 3-dimensional ultrasound for measurement of gastric volumes in healthy adults and adolescents. J Pediatr Gastroenterol Nutr 2009 Mar; 48(3):287-93.
    View PubMed
  40. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond) 2009 Mar; 33(3):342-53. Epub 2009 Jan 13.
    View PubMed
  41. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil 2009 Feb; 21(2):128-35. Epub 2008 Sep 18.
    View PubMed
  42. Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2009 Feb; 16(1):53-9.
    View PubMed
  43. Sweetser S, Busciglio IA, Camilleri M, Bharucha AE, Szarka LA, Papathanasopoulos A, Burton DD, Eckert DJ, Zinsmeister AR. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2009 Feb; 296(2):G295-301. Epub 2008 Nov 25.
    View PubMed
  44. Gibbons SJ, De Giorgio R, Pellegrini MS, Garrity-Park MM, Miller SM, Schmalz PF, Young-Fadok TM, Larson DW, Dozois EJ, Camilleri M, Stanghellini V, Szurszewski JH, Farrugia G. Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil 2009 Jan; 21(1):85-93. Epub 2008 Sep 16.
    View PubMed
  45. Dalla Man C, Bock G, Giesler PD, Serra DB, Ligueros Saylan M, Foley JE, Camilleri M, Toffolo G, Cobelli C, Rizza RA, Vella A. Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes. Diabetes Care 2009 Jan; 32(1):14-8. Epub 2008 Oct 17.
    View PubMed
  46. Gibbons SJ, De Giorgio R, Pellegrini MS, Garrity-Park MM, Miller SM, Schmalz PF, Young-Fadok TM, Larson DW, Dozois EJ, Camilleri M, Stanghellini V, Szurszewski JH, Farrugia G. Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil 2009 Jan; 21(1):85-93 Epub 2008 Sep 16.
    View PubMed
  47. Fidler J, Bharucha AE, Camilleri M, Camp J, Burton D, Grimm R, Riederer SJ, Robb RA, Zinsmeister AR. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil 2009 Jan; 21(1):42-51. Epub 2008 Oct 06.
    View PubMed
  48. Gibbons SJ, De Giorgio R, Pellegrini MS, Garrity-Park MM, Miller SM, Schmalz PF, Young-Fadok TM, Larson DW, Dozois EJ, Camilleri M, Stanghellini V, Szurszewski JH, Farrugia G. Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil 2009 Jan; 21(1):85-93. Epub 2008 Sep 16.
    View PubMed
  49. Camilleri M, Chang L. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology 2008 Dec; 135(6):1877-91. Epub 2008 Oct 09.
    View PubMed
  50. Camilleri M. Drug development and IBS drugs: experience from the past, current challenges, and proposal for the future. Curr Opin Pharmacol 2008 Dec; 8(6):671-6. Epub 2008 Jul 09.
    View PubMed
  51. Camilleri M, Bharucha AE, di Lorenzo C, Hasler WL, Prather CM, Rao SS, Wald A. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008 Dec; 20(12):1269-82.
    View PubMed
  52. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Deacon CF, Foley JE, Rizza RA, Camilleri M. The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study. Clin Endocrinol (Oxf) 2008 Nov; 69(5):737-44. Epub 2008 Mar 10.
    View PubMed
  53. Grudell AB, Sweetser S, Camilleri M, Eckert DJ, Vazquez-Roque MI, Carlson PJ, Burton DD, Braddock AE, Clark MM, Graszer KM, Kalsy SA, Zinsmeister AR. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology 2008 Oct; 135(4):1142-54. Epub 2008 Jul 16.
    View PubMed
  54. Camilleri M. Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil 2008 Sep; 20(9):971-9.
    View PubMed
  55. Bharucha AE, Charkoudian N, Andrews CN, Camilleri M, Sletten D, Zinsmeister AR, Low PA. Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans. Am J Physiol Regul Integr Comp Physiol 2008 Sep; 295(3):R874-80. Epub 2008 Jul 02.
    View PubMed
  56. Camilleri M. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol 2008 Sep; 42 Suppl 3 Pt 1:S123-5.
    View PubMed
  57. Delgado-Aros S, Camilleri M, Garcia MA, Burton D, Busciglio I. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol 2008 Aug; 295(2):G382-8. Epub 2008 Jul 10.
    View PubMed
  58. Bharucha AE, Low PA, Camilleri M, Burton D, Gehrking TL, Zinsmeister AR. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res 2008 Aug; 18(4):194-202. Epub 2008 Jul 11.
    View PubMed
  59. Camilleri M. New therapeutic approaches in irritable bowel syndrome. Eur Rev Med Pharmacol Sci 2008 Aug; 12 Suppl 1:139-40.
    View PubMed
  60. Bharucha AE, Skaar T, Andrews CN, Camilleri M, Philips S, Seide B, Burton D, Baxter K, Zinsmeister AR. Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil 2008 Aug; 20(8):891-9. Epub 2008 Apr 16.
    View PubMed
  61. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008 Aug; 57(8):1140-55. Epub 2008 Apr 08.
    View PubMed
  62. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2008 Aug; 295(2):G219-25. Epub 2008 May 29.
    View PubMed
  63. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2008 Aug; 103(8):2043-50.
    View PubMed
  64. Camilleri M, McKinzie S, Busciglio I, Low PA, Sweetser S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008 Jul; 6(7):772-81. Epub 2008 May 05.
    View PubMed
  65. Andresen V, Camilleri M. Linaclotide acetate guanylate cyclase C receptor agonist treatment of irritable bowel syndrome treatment of constipation. Drugs Future 2008 Jul; 33(7):570-6.
    View PubMed
  66. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther 2008 Jun 1; 27(11):1122-31. Epub 2008 Mar 07.
    View PubMed
  67. Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson J, Zinsmeister AR. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol 2008 Jun; 6(6):635-643.e1. Epub 2008 Apr 14.
    View PubMed
  68. Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP, Marvik R, Johnsen G, Billington CJ, Moody FG, Knudson MB, Tweden KS, Vollmer M, Wilson RR, Anvari M. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery 2008 Jun; 143(6):723-31. Epub 2008 May 09.
    View PubMed
  69. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008 May 29; 358(22):2344-54.
    View PubMed
  70. Sweetser S, Camilleri M. Clinical challenges and images in GI. Hindgut dysgenesis with megacolon. Gastroenterology 2008 May; 134(5):1293, 1635.
    View PubMed
  71. Vella A, Camilleri M. Pharmacogenetics: potential role in the treatment of diabetes and obesity. Expert Opin Pharmacother 2008 May; 9(7):1109-19.
    View PubMed
  72. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 2008 May; 6(5):545-55. Epub 2008 Jan 31.
    View PubMed
  73. Grudell AB, Camilleri M, Jensen KL, Foxx-Orenstein AE, Burton DD, Ryks MD, Baxter KL, Cox DS, Dukes GE, Kelleher DL, Zinsmeister AR. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Am J Physiol Gastrointest Liver Physiol 2008 May; 294(5):G1114-9. Epub 2008 Mar 27.
    View PubMed
  74. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg 2008 Apr; 18(4):401-7. Epub 2008 Feb 20.
    View PubMed
  75. Floyd BN, Camilleri M, Andresen V, Esfandyari T, Busciglio I, Zinsmeister AR. Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models. Neurogastroenterol Motil 2008 Apr; 20(4):330-5. Epub 2007 Oct 25.
    View PubMed
  76. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil 2008 Apr; 20(4):418-29.
    View PubMed
  77. Grudell AB, Camilleri M, Carlson P, Gorman H, Ryks M, Burton D, Baxter K, Zinsmeister AR. An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil 2008 Mar; 20(3):213-9. Epub 2007 Oct 17.
    View PubMed
  78. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil 2008 Mar; 20(3):185-96.
    View PubMed
  79. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil 2008 Mar; 20(3):185-96.
    View PubMed
  80. Camilleri M, Cowen T, Kochi TR. Enteric neuro degeneration in ageing. Neurogastroenterol Motil 2008 Mar; 20(3):185-96.
    View PubMed
  81. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ Jr, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008 Mar; 103(3):753-63. Epub 2007 Nov 19.
    View PubMed
  82. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil 2008 Mar; 20(3):185-96.
    View PubMed
  83. Aerssens J, Camilleri M, Talloen W, Thielemans L, Goehlmann HWH, Van den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R, Coulie B. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clinical Gastroenterology & Hepatology 2008 Feb; 6(2):194-205.
    View PubMed
  84. Aerssens J, Camilleri M, Talloen W, Thielemans L, Gohlmann HW, Van Den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R, Coulie B. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008 Feb; 6(2):194-205.
    View PubMed
  85. Camilleri M, Carlson P, McKinzie S, Grudell A, Busciglio I, Burton D, Baxter K, Ryks M, Zinsmeister AR. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am J Physiol Gastrointest Liver Physiol 2008 Jan; 294(1):G13-9. Epub 2007 Oct 25.
    View PubMed
  86. Mariani A, Camilleri M, Petersen IA, Ward EM, Farrugia G, Kelly DG, Podratz KC. Audit of suspected chronic intestinal pseudo-obstruction in patients with gynecologic cancer. Eur J Gynaecol Oncol 2008; 29(6):578-82.
    View PubMed
  87. Camilleri M, Saito YA. Pharmacogenomics in gastrointestinal disorders. Methods Mol Biol 2008; 448:395-412.
    View PubMed
  88. Choi KM, Zhu J, Stoltz GJ, Vernino S, Camilleri M, Szurszewski JH, Gibbons SJ, Farrugia G. Determination of gastric emptying in nonobese diabetic mice. Am J Physiol Gastrointest Liver Physiol 2007 Nov; 293(5):G1039-45. Epub 2007 Sep 20.
    View PubMed
  89. Szarka LA, Camilleri M, Burton D, Fox JC, McKinzie S, Stanislav T, Simonson J, Sullivan N, Zinsmeister AR. Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol 2007 Nov; 5(11):1268-75. Epub 2007 Sep 27.
    View PubMed
  90. Foxx-Orenstein AE, Camilleri M, Szarka LA, McKinzie S, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial. Neurogastroenterol Motil 2007 Oct; 19(10):821-30. Epub 2007 May 21.
    View PubMed
  91. Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology 2007 Sep; 133(3):761-8. Epub 2007 Jul 03.
    View PubMed
  92. Houghton LA, Cremonini F, Camilleri M, Busciglio I, Fell C, Cox V, Alpers DH, Dewit OE, Dukes GE, Gray E, Lea R, Zinsmeister AR, Whorwell PJ. Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterol Motil 2007 Sep; 19(9):732-43.
    View PubMed
  93. Tremaine WJ, Camilleri M. Ethical issues concerning therapeutic studies in inflammatory bowel disease. Inflamm Bowel Dis 2007 Sep; 13(9):1141-5.
    View PubMed
  94. Andrews CN, Bharucha AE, Camilleri M, Low PA, Seide BM, Burton DD, Nickander KK, Baxter KL, Zinsmeister AR. Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans. Neurogastroenterol Motil 2007 Sep; 19(9):716-23.
    View PubMed
  95. Camilleri M. Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications. Neurogastroenterol Motil 2007 Aug; 19 Suppl 2:40-5.
    View PubMed
  96. Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol 2007 Jul; 293(1):G137-45. Epub 2007 Mar 29.
    View PubMed
  97. Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol 2007 Jul; 5(7):829-37.
    View PubMed
  98. Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil 2007 Jul; 19(7):545-52.
    View PubMed
  99. Camilleri M, Grudell AB. Appetite and obesity: a gastroenterologist's perspective. Neurogastroenterol Motil 2007 May; 19(5):333-41.
    View PubMed
  100. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Dunning BE, Foley JE, Rizza RA, Camilleri M. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes 2007 May; 56(5):1475-80.
    View PubMed
  101. Camilleri M, Cortese DA. Managing conflict of interest in clinical practice. Mayo Clin Proc 2007 May; 82(5):607-14.
    View PubMed
  102. Andrews CN, Bharucha AE, Camilleri M, Low PA, Seide B, Burton D, Baxter K, Zinsmeister AR. Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults. Am J Physiol Gastrointest Liver Physiol 2007 May; 292(5):G1359-65. Epub 2007 Feb 08.
    View PubMed
  103. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol 2007 May; 5(5):534-40. Epub 2007 Apr 11.
    View PubMed
  104. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil 2007 Mar; 19(3):180-7.
    View PubMed
  105. Camilleri M, Dubnansky EC, Rustgi AK. Conflicts of interest and disclosures in publications. Clin Gastroenterol Hepatol 2007 Mar; 5(3):268-73.
    View PubMed
  106. Camilleri M. Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment? Neurogastroenterol Motil 2007 Feb; 19(2):77-84.
    View PubMed
  107. Grudell AB, Camilleri M. The role of peptide YY in integrative gut physiology and potential role in obesity. Curr Opin Endocrinol Diabetes Obes 2007 Feb; 14(1):52-7.
    View PubMed
  108. Camilleri M, Vazquez-Roque MI, Burton D, Ford T, McKinzie S, Zinsmeister AR, Druzgala P. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil 2007 Jan; 19(1):30-8.
  109. Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Gohlmann H, van den Wyngaert I, Coulie B. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 2007 Jan; 132(1):17-25.
    View PubMed
  110. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007 Jan; 19(Suppl 1):62-88.
    View PubMed
  111. Camilleri M, Vazquez-Roque MI, Burton D, Ford T, McKinzie S, Zinsmeister AR, Druzgala P. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil 2007 Jan; 19(1):30-8.
    View PubMed
  112. Camilleri M. Gastroenterology and hepatology clinical research update: 2005-2006. Clin Gastroenterol Hepatol 2006 Dec; 4(12):1428-33. Epub 2006 Sep 01.
    View PubMed
  113. Xue L, Camilleri M, Locke GR 3rd, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G. Serotonergic modulation of murine fundic tone. Am J Physiol Gastrointest Liver Physiol 2006 Dec; 291(6):G1180-6. Epub 2006 Jul 27.
    View PubMed
  114. Camilleri M. Is there a role for probiotics in irritable bowel syndrome? Dig Liver Dis 2006 Dec; 38 Suppl 2:S266-9.
    View PubMed
  115. Dalla Man C, Camilleri M, Cobelli C. A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng 2006 Dec; 53(12 Pt 1):2472-8.
    View PubMed
  116. Vazquez Roque MI, Camilleri M, Stephens DA, Jensen MD, Burton DD, Baxter KL, Zinsmeister AR. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology 2006 Dec; 131(6):1717-24. Epub 2006 Oct 15.
    View PubMed
  117. Chial HJ, Camilleri M. A twenty-one-year-old college student with postprandial regurgitation and weight loss. Clin Gastroenterol Hepatol 2006 Nov; 4(11):1314-7. Epub 2006 Oct 23.
    View PubMed
  118. Cremonini F, Camilleri M, Roque MV, Mckinzie S, Burton D, Baxter K, Zinsmeister AR. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology 2006 Nov; 131(5):1431-9.
    View PubMed
  119. Cremonini F, Camilleri M, Vazquez Roque M, McKinzie S, Burton D, Baxter K, Zinsmeister AR. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology 2006 Nov; 131(5):1431-9. Epub 2006 Sep 20.
    View PubMed
  120. Grudell AB, Camilleri M, Burton DD, Stephens DA. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. Aliment Pharmacol Ther 2006 Oct 1; 24(7):1037-43.
    View PubMed
  121. Gonenne J, Esfandyari T, Camilleri M, Burton DD, Stephens DA, Baxter KL, Zinsmeister AR, Bharucha AE. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil 2006 Oct; 18(10):911-8.
    View PubMed
  122. Saito YA, Camilleri M. Clinical application of pharmacogenetics in gastrointestinal diseases. Expert Opin Pharmacother 2006 Oct; 7(14):1857-69.
    View PubMed
  123. Esfandyari T, Camilleri M, Ferber I, Burton D, Baxter K, Zinsmeister AR. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil 2006 Sep; 18(9):831-8.
    View PubMed
  124. Camilleri M. New imaging in neurogastroenterology: an overview. Neurogastroenterol Motil 2006 Sep; 18(9):805-12.
    View PubMed
  125. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006 Aug; 131(2):640-58.
    View PubMed
  126. Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil 2006 Aug; 18(8):595-607.
    View PubMed
  127. Camilleri M. Management of patients with chronic abdominal pain in clinical practice. Neurogastroenterol Motil 2006 Jul; 18(7):499-506.
    View PubMed
  128. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology 2006 Jun; 130(7):1985-94.
    View PubMed
  129. Camilleri M, Bharucha AE, Ueno R, Burton D, Thomforde GM, Baxter K, McKinzie S, Zinsmeister AR. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2006 May; 290(5):G942-7.
    View PubMed
  130. Andresen V, Camilleri M. Challenges in drug development for functional gastrointestinal disorders. Part II: visceral pain. Neurogastroenterol Motil 2006 May; 18(5):354-60.
    View PubMed
  131. Andresen V, Camilleri M. Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia. Neurogastroenterol Motil 2006 May; 18(5):346-53.
    View PubMed
  132. Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol 2006 May; 101(5):1129-39.
    View PubMed
  133. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology 2006 Apr; 130(5):1466-79.
    View PubMed
  134. Camilleri M, Bueno L, de Ponti F, Fioramonti J, Lydiard RB, Tack J. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology 2006 Apr; 130(5):1421-34.
    View PubMed
  135. Skoog SM, Bharucha AE, Camilleri M, Burton DD, Zinsmeister AR. Effects of an osmotically active agent on colonic transit. Neurogastroenterol Motil 2006 Apr; 18(4):300-6.
    View PubMed
  136. Camilleri CE, Carlson PJ, Camilleri M, Castillo EJ, Locke GR 3rd, Geno DM, Stephens DA, Zinsmeister AR, Urrutia R. A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol 2006 Mar; 101(3):581-92. Epub 2006 Feb 08.
    View PubMed
  137. Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, Walker WA, Fedorak RN, Camilleri M. Recommendations for probiotic use. J Clin Gastroenterol 2006 Mar; 40(3):275-8.
    View PubMed
  138. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol 2006 Mar; 40(3):264-9.
    View PubMed
  139. Park MI, Ferber I, Camilleri M, Allenby K, Trillo R, Burton D, Zinsmeister AR. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil 2006 Jan; 18(1):28-36.
    View PubMed
  140. Xue L, Locke GR, Camilleri M, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G. Effect of modulation of serotonergic, cholinergic, and nitrergic pathways on murine fundic size and compliance measured by ultrasonomicrometry. Am J Physiol Gastrointest Liver Physiol 2006 Jan; 290(1):G74-82. Epub 2005 Sep 15.
    View PubMed
  141. Schiller LR, Camilleri M. Lubiprostone: profile report. Drugs and Therapy Perspectives 2006; 22(9):5-6.
    View PubMed
  142. Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs 2006; 66(8):1073-88.
    View PubMed
  143. Cremonini F, Houghton LA, Camilleri M, Ferber I, Fell C, Cox V, Castillo EJ, Alpers DH, Dewit OE, Gray E, Lea R, Zinsmeister AR, Whorwell PJ. Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterology & Motility 2005 Dec; 17(6):810-20.
    View PubMed
  144. Camilleri M. GIH clinical research update: 2004-2005. Clin Gastroenterol Hepatol 2005 Dec; 3(12):1161-6.
  145. Kim HJ, Roque MIV, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005 Oct; 17(5):687-96.
    View PubMed
  146. Camilleri M, Gamble GL, Kopecky SL, Wood MB, Hockema ML. Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy. Mayo Clin Proc 2005 Oct; 80(10):1340-6.
    View PubMed
  147. Delgado-Aros S, Camilleri M, Castillo EJ, Cremonini F, Stephens D, Ferber I, Baxter K, Burton D, Zinsmeister AR. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol 2005 Oct; 3(10):997-1006.
    View PubMed
  148. Cremonini F, Camilleri M, Gonenne J, Stephens D, Oenning L, Baxter K, Foxx-Orenstein A, Burton D. Effect of somatostatin analog on postprandial satiation in obesity. Obes Res 2005 Sep; 13(9):1572-9.
    View PubMed
  149. Gonenne J, Camilleri M, Ferber I, Burton D, Baxter K, Keyashian K, Foss J, Wallin B, Du W, Zinsmeister AR. Effect of alvimopan and codeine on gastrointestinal transit: A randomized controlled study. Clin Gastroenterol Hepatol 2005 Aug; 3(8):784-91.
    View PubMed
  150. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol 2005 Aug; 289(2):G261-6.
  151. Camilleri M. Pharmacogenomics and functional gastrointestinal disorders. Pharmacogenomics 2005 Jul; 6(5):491-501.
    View PubMed
  152. Nickander KK, Carlson PJ, Urrutia RA, Camilleri M, Low PA. A screen of candidate genes and influence of beta2-adrenergic receptor genotypes in postural tachycardia syndrome. Auton Neurosci 2005 Jun 15; 120(1-2):97-103.
    View PubMed
  153. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005 Jun; 3(6):543-52.
    View PubMed
  154. Park MI, Camilleri M. Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am 2005 Jun; 34(2):305-17.
    View PubMed
  155. Delgado-Aros S, Camilleri M. Visceral hypersensitivity. J Clin Gastroenterol 2005 May-Jun; 39(4 Suppl S):S194-S203.
  156. Chitkara DK, Camilleri M, Zinsmeister AR, Burton D, El-Youssef M, Freese D, Walker L, Stephens D. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr 2005 Apr; 146(4):500-5.
    View PubMed
  157. Camilleri M. Alvimopan, a selective peripherally acting mu-opioid antagonist. Neurogastroenterol Motil 2005 Apr; 17(2):157-65.
    View PubMed
  158. Park MI, Camilleri M. Gastric motor and sensory functions in obesity. Obes Res 2005 Mar; 13(3):491-500.
    View PubMed
  159. Cremonini F, Camilleri M, McKinzie S, Carlson P, Camilleri CE, Burton D, Thomforde G, Urrutia R, Zinsmeister AR. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: A pharmacodynamic and pharmacogenomic study. Am J Gastroenterol 2005 Mar; 100(3):652-63.
    View PubMed
  160. Gonenne J, Castillo EJ, Camilleri M, Burton D, Thomforde GM, Baxter KL, Zinsmeister AR. Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia? Neurogastroenterol Motil 2005 Feb; 17(1):44-50.
    View PubMed
  161. Camilleri M. Etiology and pathophysiology of irritable bowel syndrome and chronic constipation. Advanced Studies in Medicine 2005; 5(10 B):S955-64.
  162. Talley NJ, Camilleri M, Chitkara DK, Bouras E, Locke GR, Burton D, Rucker MJ, Thapa P, Zinsmeister AR. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: A randomized, double-blind, placebo-controlled study. Digestion 2005; 72(2-3):97-103.
    View PubMed
  163. Bouras EP, Burton DD, Camilleri M, Stephens DA, Thomforde GM. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil 2004 Dec; 16(6):729-35.
    View PubMed
  164. Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004 Dec; 127(6):1685-94.
    View PubMed
  165. Castillo EJ, Camilleri M, Locke GR, Burton DD, Stephens DA, Geno DM, Zinsmeister AR. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004 Nov; 2(11):985-96.
    View PubMed
  166. Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2004 Oct; 2(10):895-904.
    View PubMed
  167. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004 Oct; 16(5):515-31.
    View PubMed
  168. De Schepper H, Camilleri M, Cremonini F, Foxx-Orenstein A, Burton D. Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil 2004 Oct; 16(5):567-73.
    View PubMed
  169. Hicks GA, Dehaven-Hudkins DL, Camilleri M. Opiates in the control of gastrointestinal tract function: current knowledge and new avenues for research. Neurogastroenterol Motil 2004 Oct; 16(Suppl 2):67-70.
    View PubMed
  170. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol 2004 Sep; 99(9):1801-6.
    View PubMed
  171. Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol 2004 Aug; 99(8):1579-84.
    View PubMed
  172. De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004 Aug; 16(4):383-94.
    View PubMed
  173. Castillo EJ, Delgado-Aros S, Camilleri M, Burton D, Stephens D, O'Connor-Semmes R, Walker A, Shachoy-Clark A, Zinsmeister AR. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2004 Aug; 287(2):G363-9.
  174. Vella A, Camilleri M, Rizza RA. The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care 2004 Jul; 7(4):479-84.
    View PubMed
  175. De Schepper HU, Cremonini F, Chitkara D, Camilleri M. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 2004 Jun; 16(3):275-85.
    View PubMed
  176. Camilleri M. Advances in pharmacological treatments of IBS. Journal of Pediatric Gastroenterology & Nutrition 2004 Jun; 39(Suppl 3):S766-7.
    View PubMed
  177. Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, McKinzie S, Zinsmeister AR, Urrutia R. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004 Jun; 53(6):829-37.
    View PubMed
  178. Camilleri M. Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol 2004 Apr; 141(8):1237-48.
    View PubMed
  179. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil 2004 Apr; 16(2):135-42.
    View PubMed
  180. Camilleri M. Chronic diarrhea: a review on pathophysiology and management for the clinical gastroenterologist. Clinical Gastroenterology & Hepatology 2004 Mar; 2(3):198-206.
    View PubMed
  181. Camilleri M. Nonmalignant gastrointestinal syndromes in the elderly: part II -- midgut and hindgut diseases. Clinical Geriatrics 2004 Mar; 12(3):24, 25-7, 31-2.
  182. Camilleri M. Nonmalignant gastrointestinal syndromes in the elderly: part I -- alterations in physiology and foregut diseases. Clinical Geriatrics 2004 Feb; 12(2):38-40, 41-3.
  183. Delgado-Aros S, Cremonini F, Castillo JE, Chial HJ, Burton DD, Ferber I, Camilleri M. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology 2004 Feb; 126(2):432-40.
    View PubMed
  184. Delgado-Aros S, Camilleri M. [Clinical management of acute colonic pseudo-obstruction in patients: a systematic review of the literature]. [Review] [107 refs] [Spanish]. Gastroenterol Hepatol 2003 Dec; 26(10):646-55.
    View PubMed
  185. Chitkara DK, Delgado-Aros S, Bredenoord AJ, Cremonini F, El-Youssef M, Freese D, Camilleri M. Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr 2003 Nov; 143(5):609-13.
    View PubMed
  186. Camilleri M. GI clinical research 2002-2003: the year in review. Clinical Gastroenterology & Hepatology 2003 Nov; 1(6):415-20.
    View PubMed
  187. Foxx-Orenstein A, Camilleri M, Stephens D, Burton D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 2003 Nov; 52(11):1555-61.
    View PubMed
  188. Lembo A, Camilleri M. Current concepts: Chronic constipation. N Engl J Med 2003 Oct 2; 349(14):1360-8.
    View PubMed
  189. Delgado-Aros S, Chial HJ, Cremonini F, Ferber I, McKinzie S, Burton DD, Camilleri M. Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Alimentary Pharmacology & Therapeutics 2003 Sep 1; 18(5):507-14.
    View PubMed
  190. Cremonini F, Di Caro S, Delgado-Aros S, Sepulveda A, Gasbarrini G, Gasbarrini A, Camilleri M. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 2003 Aug 1; 18(3):279-89.
    View PubMed
  191. Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM, Stephens D. Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil 2003 Aug; 15(4):435-43.
    View PubMed
  192. Zangeneh F, Basu R, Shah P, Arora P, Camilleri M, Rizza RA. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab 2003 Aug; 285(2):E280-6.
    View PubMed
  193. Delgado-Aros S, Cremonini F, Bredenoord AJ, Camilleri M. Systematic review and meta-analysis: does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain? Alimentary Pharmacology & Therapeutics 2003 Jul 15; 18(2):167-74.
    View PubMed
  194. Bredenoord AJ, Chial HJ, Camilleri M, Mullan BP, Murray JA. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol 2003 Jul; 1(4):264-72.
    View PubMed
  195. Delgado-Aros S, Camilleri M. Pseudo-obstruction in the critically ill. Best Practice & Research in Clinical Gastroenterology 2003 Jun; 17(3):427-44.
    View PubMed
  196. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003 Jun; 98(6):1309-14.
    View PubMed
  197. Chial HJ, Camilleri M, Ferber I, Delgado-Aros S, Burton D, McKinzie S, Zinsmeister AR. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clinical Gastroenterology & Hepatology 2003 May; 1(3):211-8.
    View PubMed
  198. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2003 Apr 1; 17(7):895-904.
    View PubMed
  199. Delgado-Aros S, Chial HJ, Camilleri M, Szarka LA, Weber FT, Jacob J, Ferber I, McKinzie S, Burton DD, Zinsmeister AR. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol 2003 Apr; 284(4):G558-G566.
    View PubMed
  200. Camilleri M, Kim DY, McKinzie S, Kim HJ, Thomforde GM, Burton DD, Low PA, Zinsmeister AR. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome. Clinical Gastroenterology & Hepatology 2003 Mar; 1(2):111-21.
    View PubMed
  201. Cremonini F, Delgado-Aros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 2003 Feb; 15(1):79-86.
    View PubMed
  202. Camilleri M. Diagnosis and treatment of enteric neuromuscular diseases. Clin Auton Res 2003 Feb; 13(1):10-5.
    View PubMed
  203. Chial HJ, Camilleri M, Williams DE, Litzinger K, Perrault J. Rumination syndrome in children and adolescents: Diagnosis, treatment, and prognosis. Pediatrics 2003 Jan; 111(1):158-62.
    View PubMed
  204. Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol 2003 Jan; 284(1):G130-7.
    View PubMed
  205. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002 Dec; 123(6):2108-31.
    View PubMed
  206. Bouras EP, Delgado-Aros S, Camilleri M, Castillo EJ, Burton DD, Thomforde GM, Chial HJ. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Gut 2002 Dec; 51(6):781-6.
    View PubMed
  207. Camilleri M. Drugs targeting functional bowel disorders: lessons from drug trials. Current Opinion in Pharmacology 2002 Dec; 2(6):684-90.
    View PubMed
  208. Cremonini F, Mullan BP, Camilleri M, Burton DD, Rank MR. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Alimentary Pharmacology & Therapeutics 2002 Oct; 16(10):1781-90.
    View PubMed
  209. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, McKinzie S, Urrutia R. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002 Aug; 123(2):425-32.
    View PubMed
  210. Camilleri M, Heading RC, Thompson WG. Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2002 Aug; 16(8):1407-30.
    View PubMed
  211. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab 2002 Aug; 283(2):E259-66.
    View PubMed
  212. Camilleri M. Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls. Gut 2002 Jul; 51(Suppl 1):I34-I40.
    View PubMed
  213. Camilleri M. Serotonergic modulation of visceral sensation: lower gut. Gut 2002 Jul; 51(Suppl 1):I81-6.
    View PubMed
  214. Chial HJ, Camilleri C, Delgado-Aros S, Burton D, Thomforde G, Ferber I, Camilleri M. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil 2002 Jun; 14(3):249-53.
    View PubMed
  215. Chial HJ, Camilleri M. Gender differences in irritable bowel syndrome. J Gend Specif Med 2002 May-Jun; 5(3):37-45.
    View PubMed
  216. Vella A, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, Rizza RA, Klein PD. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil 2002 Apr; 14(2):123-31.
    View PubMed
  217. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol 2002 Mar; 282(3):G424-31.
    View PubMed
  218. Kuo B, Camilleri M, Burton D, Viramontes B, McKinzie S, Thomforde G, O'Connor MK, Brinkmann BH. Effects of 5-HT3 antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther 2002 Feb; 16(2):225-33.
    View PubMed
  219. Chial HJ, McAlpine DE, Camilleri M. Anorexia nervosa: Manifestations and management for the gastroenterologist. Am J Gastroenterol 2002 Feb; 97(2):255-69.
    View PubMed
  220. Pardi DS, Loftus EV, Camilleri M. Treatment of inflammatory bowel disease in the elderly - An update. Drugs & Aging 2002; 19(5):355-63.
    View PubMed
  221. Camilleri M. Advances in diabetic gastroparesis. Reviews in Gastroenterological Disorders 2002; 2(2):47-56.
    View PubMed
  222. Liau SS, Camilleri M, Kim DY, Stephens D, Burton DD, O'Connor MK. Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging. Neurogastroenterol Motil 2001 Dec; 13(6):533-42.
    View PubMed
  223. Viramontes BE, Kim DY, Camilleri M, Lee JS, Stephens D, Burton DD, Thomforde GM, Klein PD, Zinsmeister AR. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil 2001 Dec; 13(6):567-74.
    View PubMed
  224. Viramontes BE, Malcolm A, Camilleri M, Szarka LA, McKinzie S, Burton DD, Zinsmeister AR. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol 2001 Dec; 281(6):G1468-76.
  225. Kim DY, Camilleri M, Murray JA, Stephens DA, Levine JA, Burton DD. Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res 2001 Nov; 9(11):655-61.
    View PubMed
  226. Kim DY, Delgado-Aros S, Camilleri M, Samsom M, Murray JA, O'Connor MK, Brinkmann BH, Stephens DA, Lighvani SS, Burton DD. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 2001 Nov; 96(11):3099-105.
    View PubMed
  227. Viramontes BE, Camilleri M, McKinzie S, Pardi DS, Burton D, Thomforde GM. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2001 Sep; 96(9):2671-2676.
    View PubMed
  228. Camilleri M. Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist. Neurogastroenterol Motil 2001 Aug; 13(4):277-95.
    View PubMed
  229. Camilleri M, Chey WY, Mayer EA, Northcutt AR, Heath A, Dukes GE, McSorley D, Mangel AM. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001 Jul 23; 161(14):1733-40.
    View PubMed
  230. Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF. Adynamic ileus in severe Guillain-Barre syndrome. Muscle & Nerve 2001 Jul; 24(7):963-5.
    View PubMed
  231. Bharucha AE, Camilleri M. Functional abdominal pain in the elderly. Gastroenterol Clin North Am 2001 Jun; 30(2):517-529.
    View PubMed
  232. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia 2001 Jun; 44(6):729-37.
    View PubMed
  233. Coulie B, Camilleri M, Bharucha AE, Sandborn WJ, Burton D. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine and colonic motility in patients and healthy subjects. Aliment Pharmacol Ther 2001 May; 15(5):653-63.
    View PubMed
  234. Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 2001 May; 96(5):1494-8.
    View PubMed
  235. Aros SD, Camilleri M. Small-bowel motility. Curr Opin Gastroenterol 2001 Mar; 17(2):140-146.
    View PubMed
  236. Camilleri M. Review article: tegaserod. Alimentary Pharmacology & Therapeutics 2001 Mar; 15(3):277-89.
    View PubMed
  237. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes 2001 Mar; 50(3):565-72.
    View PubMed
  238. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001 Feb; 120(3):652-68.
    View PubMed
  239. Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology 2001 Feb; 120(2):354-60.
    View PubMed
  240. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol 2001 Feb; 96(2):373-9.
    View PubMed
  241. Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut 2001 Jan; 48(1):125-31.
    View PubMed
  242. Camilleri M. Novel medications for the irritable bowel syndrome: motility and sensation. J Pediatr Gastroenterol Nutr 2001; 32(Suppl 1):S35-S37.
    View PubMed
  243. Camilleri M. Pathophysiology in irritable bowel syndrome. Drug News & Perspectives 2001; 14(5):268-278.
    View PubMed
  244. Camilleri M. Dyspepsia, irritable bowel syndrome, and constipation: review and what's new. Reviews in Gastroenterological Disorders 2001; 1(1):2-17.
    View PubMed
  245. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Progress in Geriatrics: Insights into the pathophysiology and mechanisms of constipation, IBS, and diverticulosis in the elderly. Am J Geriatr Soc 2001.
  246. Kim DY, Myung SJ, Camilleri M. Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol 2000 Dec; 95(12):3365-73.
    View PubMed
  247. Camilleri M. Neurogastroenterology: evolving concepts and techniques to study motility and hypersensitivity. Digestive & Liver Disease 2000 Dec; 32(Suppl 3):S227-32.
  248. Camilleri M. Functional bowel disease: roles of sensation and motility. Schweiz Med Wochenschr 2000 Nov 18; 130(46):1772-81.
    View PubMed
  249. Bharucha AE, Camilleri M, Haydock S, Ferber I, Burton D, Cooper S, Tompson D, Fitzpatrick K, Higgins R, Zinsmeister AR. Effects of a serotonin 5-HT4 receptor antagonist SE-207266 on gastrointestinal motor and sensory function in humans. Gut 2000 Nov; 47(5):667-674.
    View PubMed
  250. Maleki D, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, Melton LJ 3rd. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000 Oct 9; 160(18):2808-16.
    View PubMed
  251. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000 Oct; 95(10):2698-709.
    View PubMed
  252. Lee JS, Camilleri M, Zinsmeister AR, Burton DD, Choi MG, Nair KS, Verlinden M. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol 2000 Oct; 95(10):2751-61.
    View PubMed
  253. Coulie B, Camilleri M. New therapies for functional bowel diseases. Curr Gastroenterol Rep 2000 Oct; 2(5):355-63.
    View PubMed
  254. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc 2000 Sep; 48(9):1142-50.
    View PubMed
  255. Thumshirn M, Coulie B, Camilleri M, Zinsmeister AR, Burton DD, Van Dyke C. Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2000 Jul; 14(7):869-78.
    View PubMed
  256. Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N, Cedarbaum JM. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology 2000 Jul; 119(1):41-50.
    View PubMed
  257. Nehra V, Bruce BK, Rath-Harvey DM, Pemberton JH, Camilleri M. Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol 2000 Jul; 95(7):1755-8.
    View PubMed
  258. Malcolm A, Camilleri M, Kost L, Burton DD, Fett SL, Zinsmeister AR. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Alimentary Pharmacology & Therapeutics 2000 Jun; 14(6):783-93.
    View PubMed
  259. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol 2000 Jun; 278(6):G946-51.
    View PubMed
  260. Lee JS, Camilleri M, Zinsmeister AR, Burton DD, Kost LJ, Klein PD. A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut 2000 Jun; 46(6):768-73.
    View PubMed
  261. Camilleri M, Williams DE. Economic burden of irritable bowel syndrome - proposed strategies to control expenditures. Pharmacoeconomics 2000 Apr; 17(4):331-338.
    View PubMed
  262. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet 2000 Mar 25; 355(9209):1035-40.
    View PubMed
  263. Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000 Mar; 118(3):463-8.
    View PubMed
  264. Malcolm A, Camilleri M. Coloanal motor coordination in association with high-amplitude colonic contractions after pharmacological stimulation. Am J Gastroenterol 2000 Mar; 95(3):715-9.
    View PubMed
  265. Camilleri M. Pharmacology and clinical experience with alosetron. Expert Opin Investig Drugs 2000 Jan; 9(1):147-59.
    View PubMed
  266. Camilleri M. Ten secrets for development of drugs for functional gastrointestinal diseases. Comments from the Editors Gastroenterology 2000; 118:653.
  267. Kellow JE, Delvaux MM, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Principles of applied neurogastroenterology: motility/sensation - sensation Rome II: The Functional Gastrointestinal Disorders, 2nd ed. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Lawrence, KS: Allen Press, Inc., 2000, pp. 91-156 2000.
  268. Lee JS, Camilleri M. Image of the month. Gastroenterology 2000; 119:614.
  269. Kuiken SD, Samsom M, Camilleri M, Mullan BP, Burton DD, Kost LJ, Hardyman TJ, Brinkmann BH, O'Connor MK. Development of a test to measure gastric accommodation in humans. Am J Physiol 1999 Dec; 277(6 Pt 1):G1217-21.
    View PubMed
  270. Camilleri M, Calobrisi SD. Skin eruptions in the diaper area. Curr Probl Dermatol 1999 Nov-Dec; 11(6):213-244.
  271. Camilleri M. Clinical subgroups of chronic constipation: exploring the potential of polyethylene glycol. Italian Journal of Gastroenterology & Hepatology 1999 Nov; 31(Suppl 3):S253-4.
  272. Bouras EP, O'Brien TJ, Camilleri M, O'Connor MK, Mullan BP. Cerebral topography of rectal stimulation using single photon emission computed tomography. Am J Physiol 1999 Sep; 277(3 Pt 1):G687-94.
    View PubMed
  273. Camilleri M, Mayer EA, Drossman DA, Heath A, Dukes GE, McSorley D, Kong S, Mangel AW, Northcutt AR. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Alimentary Pharmacology & Therapeutics 1999 Sep; 13(9):1149-59.
    View PubMed
  274. Kellow JE, Delvaux M, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut 1999 Sep; 45(Suppl 2):17-24.
    View PubMed
  275. Camilleri M. Review article: clinical evidence to support current therapies of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 1999 May; 13(Suppl 2):48-53.
    View PubMed
  276. Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation of colonic transit by the benzofuran 5HT(4) agonist, prucalopride, in healthy humans. Gut 1999 May; 44(5):682-686.
    View PubMed
  277. Mueller LA, Camilleri M, Emslie-Smith AM. Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology 1999 Apr; 116(4):959-63.
    View PubMed
  278. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha(2)-adrenergic agents in humans. Gastroenterology 1999 Mar; 116(3):573-85.
    View PubMed
  279. Mollen RM, Salvioli B, Camilleri M, Burton D, Kost LJ, Phillips SF, Pemberton JH. The effects of biofeedback on rectal sensation and distal colonic motility in patients with disorders of rectal evacuation: evidence of an inhibitory rectocolonic reflex in humans? Am J Gastroenterol 1999 Mar; 94(3):751-6.
    View PubMed
  280. Camilleri M. Motor function in irritable bowel syndrome. Can J Gastroenterol 1999 Mar; 13(Suppl A):8A-11A.
    View PubMed
  281. Scolapio JS, Camilleri M, Weckwerth JA, Romano M. Audit of the treatment of malnutrition due to chronic intestinal pseudo-obstruction with enteral nutrition. Nutr Clin Pract 1999 Feb; 14(1):29-32.
  282. Forstner-Barthell AW, Murr MM, Nitecki S, Camilleri M, Prather CM, Kelly KA, Sarr MG. Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg 1999 Jan-Feb; 3(1):15-21, discussion 21-3.
    View PubMed
  283. Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999 Jan; 44(1):55-64.
    View PubMed
  284. Harewood GC, Coulie B, Camilleri M, Rath-Harvey D, Pemberton JH. Descending perineum syndrome: audit of clinical and laboratory features and outcome of pelvic floor retraining. Am J Gastroenterol 1999 Jan; 94(1):126-30.
    View PubMed
  285. Camilleri M. Chronic intestinal pseudo-obstruction Approach to the Patient with Chronic Gastrointestinal Disorders. Corazziari E, ed. Millan: Messaggi srl, 1999:pp. 271-93.
  286. Camilleri M. Therapeutic approach to the patient with irritable bowel syndrome. Am J Med 1999; 107(5 Suppl 1):27-32.
    View PubMed
  287. Camilleri M. Review article: Functional bowel disease: a challenging frontier in gastroenterology. Maltese Medical Journal 1999; 11:4-14.
  288. Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med 1999; 50:37-55.
    View PubMed
  289. Wagaman JR, Williams DE, Camilleri M. Behavioral intervention for the treatment of rumination. Journal of Pediatric Gastroenterology & Nutrition 1998 Nov; 27(5):596-8.
    View PubMed
  290. Maleki D, Camilleri M, Burton DD, Rath-Harvey DM, Oenning L, Pemberton JH, Low PA. Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci 1998 Nov; 43(11):2373-8.
    View PubMed
  291. Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998 Sep; 115(3):747-62.
    View PubMed
  292. Thumshirn M, Camilleri M, Hanson RB, Williams DE, Schei AJ, Kammer PP. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol Gastrointest Liver Physiol 1998 Aug; 275(2):G 314-G 321.
  293. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998 Jul; 93(7):1085-9.
    View PubMed
  294. Saslow SB, Scolapio JS, Camilleri M, Forstrom LA, Thomforde GM, Burton DD, Rubin J, Pitot HC, Zinsmeister AR. Medium term effects of a new 5HT(3) antagonist, alosetron, in patients with carcinoid diarrhea. Gut 1998 May; 42(5):628-34.
    View PubMed
  295. Choi MG, Camilleri M, Burton DD, Johnson S, Edmonds A. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers. Journal of Pharmacology & Experimental Therapeutics 1998 Apr; 285(1):37-40.
    View PubMed
  296. Camilleri M, Ford MJ. Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Alimentary Pharmacology & Therapeutics 1998 Apr; 12(4):287-302.
    View PubMed
  297. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception - reproducibility and response to different distensions. Am J Physiol Gastrointest Liver Physiol 1998 Mar; 274(3):G 584-G 590.
  298. Mullan BP, Camilleri M, Hung JC. Activated charcoal as a potential radioactive marker for gastrointestinal studies. Nucl Med Commun 1998 Mar; 19(3):237-40.
    View PubMed
  299. Saslow SB, Thumshirn M, Camilleri M, Locke GR 3rd, Thomforde GM, Burton DD, Hanson RB. Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers. Dig Dis Sci 1998 Feb; 43(2):258-64.
    View PubMed
  300. Farrugia G, Nitecki S, Harty GJ, Camilleri M, Szurszewski JH. The effect of flufenamic acid on gastrointestinal myoelectrical activity and transit time in dogs. Gut 1998 Feb; 42(2):258-65.
    View PubMed
  301. Frank JW, Camilleri M, Thomforde GM, Dinneen SF, Rizza RA. Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans. Metabolism: Clinical & Experimental 1998 Jan; 47(1):7-12.
    View PubMed
  302. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. Reproducibility and simplification of c-13-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998 Jan; 93(1):92-8.
    View PubMed
  303. Camilleri M. Gastric emptying in diabetes mellitus: potential strategies to achieve euglycemia. Motility 1998; issue 43:4-6.
  304. Camilleri M. Gastrointestinal motility disorders. Scientific American Medicine. Dale DC, Federman DD, eds. New York: Scientific American Medicine Publishers, 1998.
  305. Camilleri M. Motor function in functional dyspepsia and irritable bowel syndrome. Functional Dyspepsia and Irritable bowel syndrome: Concepts and Controversies. Goebell H, Holtmann G, Talley N, eds. Lancaster, U.K.: Kluwer Academic Publishers, 1998:pp 103-12.
  306. Camilleri M, Maleki D, Barnett D. Gastrointestinal complications of diabetes mellitus. The Uncomplicated Guide to Diabetes Complications. Levin ME, Pfeiffer MA, eds. Alexandria, VA: American Diabetes Association, 1998:pp. 236-49.
  307. Fujimura J, Camilleri M, Low PA, Novak V, Novak P, Opfer-Gehrking TL. Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J Auton Nerv Syst 1997 Dec 3; 67(1-2):15-23.
    View PubMed
  308. Saslow SB, O'Brien MD, Camilleri M, von der Ohe M, Homburger HA, Klee GG, Pitot HC, Rubin J. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome. Am J Gastroenterol 1997 Dec; 92(12):2250-6.
    View PubMed
  309. Malcolm A, Phillips SF, Camilleri M, Hanson RB. Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol 1997 Nov; 92(11):2073-9.
    View PubMed
  310. Burton DD, Camilleri M, Mullan BP, Forstrom LA, Hung JC. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med 1997 Nov; 38(11):1807-10.
    View PubMed
  311. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol Gastrointest Liver Physiol 1997 Nov; 273(5):G 997-G1006.
  312. Bharucha AE, Novak V, Camilleri M, Zinsmeister AR, Hanson RB, Low PA. Alpha (2)-adrenergic modulation of colonic tone during hyperventilation. Am J Physiol Gastrointest Liver Physiol 1997 Nov; 273(5):G1135-G1140.
  313. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997 Oct; 113(4):1074-81.
    View PubMed
  314. Maleki D, Camilleri M, Zinsmeister AR, Rizza RA. Effect of acute hyperglycemia on colorectal motor and sensory function in humans. Am J Physiol Gastrointest Liver Physiol 1997 Oct; 273(4):G 859-G 864.
  315. Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol 1997 Sep; 92(9):1496-500.
    View PubMed
  316. Scolapio JS, Camilleri M, Fleming CR. Gastrointestinal motility considerations in patients with short-bowel syndrome. Dig Dis 1997 Jul-Oct; 15(4-5):253-62.
    View PubMed
  317. Malcolm A, Thumshirn MB, Camilleri M, Williams DE. Rumination syndrome. Mayo Clin Proc 1997 Jul; 72(7):646-52.
    View PubMed
  318. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997 Jun; 112(6):2120-37.
    View PubMed
  319. Bruninga K, Camilleri M. Colonic motility and tone after spinal cord and cauda equina injury. Am J Gastroenterol 1997 May; 92(5):891-4.
    View PubMed
  320. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997 Apr; 112(4):1155-62.
    View PubMed
  321. Charles F, Phillips SF, Camilleri M, Thomforde GM. Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc 1997 Apr; 72(4):323-8.
    View PubMed
  322. Nguyen A, Camilleri M, Kost LJ, Metzger A, Sarr MG, Hanson RB, Fett SL, Zinsmeister AR. SDZ HTF 919 stimulates canine colonic motility and transit in vivo. Journal of Pharmacology & Experimental Therapeutics 1997 Mar; 280(3):1270-6.
    View PubMed
  323. Loftus EV Jr, Farrugia G, Donohue JH, Camilleri M. Duodenal obstruction: diagnosis by gastroduodenal manometry. Mayo Clin Proc 1997 Feb; 72(2):130-2.
    View PubMed
  324. Choi MG, Camilleri M, O'Brien MD, Kammer PP, Hanson RB. A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol 1997 Feb; 92(2):297-302.
    View PubMed
  325. Camilleri M, Choi MG. Irritable bowel syndrome. Aliment Pharmacol Ther 1997 Feb; 11(1):3-15.
    View PubMed
  326. O'Brien MD, Camilleri M, Thomforde GM, Wiste JA, Hanson RB, Zinsmeister AR. Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Dig Dis Sci 1997 Jan; 42(1):26-33.
    View PubMed
  327. Whitehead WE, Delvaux M, Azpiroz F, Barlow J, Bradley L, Camilleri M, Crowell MD, Enck P, Fioramonti J, Janssens J, Mayer EA, Morteau O, Phillips SF, Thompson DG, Wingate DL. Standardization of procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. Dig Dis Sci 1997; 42:223-41.
    View PubMed
  328. Camilleri M. Diarrhea and irritable bowel syndrome: Practical approaches. Surgery and Colon & Rectum. Nicholls RJ, Dozois RR, eds. London: Churchill Livingstone, 1997:pp. 681-689.
  329. Camilleri M. Dysautonomic findings in functional gastrointestinal disorders. Functional Dyspepsia. Mearin F, ed. Barcelona, Spain: Doyma Publishers, 1997:pp. 133-138.
  330. O'Brien MD, Camilleri M, von der Ohe MR, Phillips SF, Pemberton JH, Prather CM, Wiste JA, Hanson RB. Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol 1996 Dec; 91(12):2532-8.
    View PubMed
  331. Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol 1996 Sep; 16(3):203-16.
    View PubMed
  332. Bharucha AE, Camilleri M, Ford MJ, O'Connor MK, Hanson RB, Thomforde GM. Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology 1996 Aug; 111(2):368-77.
    View PubMed
  333. Ford MJ, Camilleri M, Joyner MJ, Hanson RB. Autonomic control of colonic tone and the cold pressor test. Gut 1996 Jul; 39(1):125-129.
    View PubMed
  334. Camilleri M. Nonulcer dyspepsia: a look into the future. Mayo Clin Proc 1996 Jun; 71(6):614-22.
    View PubMed
  335. Camilleri M. Gastrointestinal problems in diabetes. Endocrinology & Metabolism Clinics of North America 1996 Jun; 25(2):361-78.
    View PubMed
  336. Camilleri M, Balm RK, Zinsmeister AR. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility. Alimentary Pharmacology & Therapeutics 1996 Jun; 10(3):403-9.
    View PubMed
  337. Zein NN, Perrault J, Camilleri M. Recurrent vomiting following Harrington rod instrumentation of the spine. Journal of Pediatric Gastroenterology & Nutrition 1996 Apr; 22(3):318-20.
    View PubMed
  338. Surrenti E, Camilleri M, Kammer PP, Prather CM, Schei AJ, Hanson RB. Antral axial forces postprandially and after erythromycin in organic and functional dysmotilities. Dig Dis Sci 1996 Apr; 41(4):697-704.
    View PubMed
  339. Farrugia G, Camilleri M, Whitehead WE. Therapeutic strategies for motility disorders. Medications, nutrition, biofeedback, and hypnotherapy. Gastroenterol Clin North Am 1996 Mar; 25(1):225-46.
    View PubMed
  340. Camilleri M, Saslow SB, Bharucha AE. Gastrointestinal sensation. Mechanisms and relation to functional gastrointestinal disorders. Gastroenterol Clin North Am 1996 Mar; 25(1):247-58.
    View PubMed
  341. Scolapio JS, Camilleri M. Nonulcer dyspepsia. Gastroenterologist 1996 Mar; 4(1):13-23.
    View PubMed
  342. Saslow SB, Camilleri M, Thomforde GM, Van Dyke CT, Pitot HC, Rubin J. Relation between fat malabsorption and transit abnormalities in human carcinoid diarrhea. Gastroenterology 1996 Feb; 110(2):405-10.
    View PubMed
  343. Camilleri M. Effect of altered control of the autonomic nervous system on gastrointestinal function. Proceedings of the International Symposium of NeuroGastroenterology. Corazziari E, ed. Berlin: Walter De Gruyter & Co., 1996:pp. 187-198.
  344. Camilleri M. Effects of somatostatin analogues on human gastrointestinal motility. Digestion 1996; 57(Suppl 1):90-2.
    View PubMed
  345. Talley NJ, Camilleri M. Epidemiological features of functional dyspepsia and irritable bowel syndrome. Clinican 1996; 14:7-13.
  346. Camilleri M, Saslow SB. Somatostatin analogs in the treatment of gastrointestinal motility disorders Advances in Gastroenterology Hepatology & Clinical Nutrition , 1996; 1:291-8.
  347. Camilleri M. Gastrointestinal neuropathies relieved by prokinetic therapy Gastroenterology Observer 1996; 15:2-3.
  348. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology 1995 Dec; 109(6):1772-80.
    View PubMed
  349. Murr MM, Sarr MG, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol 1995 Dec; 90(12):2147-51.
    View PubMed
  350. Rowe FA, Camilleri M, Forstrom LA, Batts KP, Mullan BP, Thomforde GM, Dunn W, Zinsmeister AR. A pilot study of splenic and whole body retention of autologous radiolabeled leukocytes in the assessment of severity in inflammatory colitis. Am J Gastroenterol 1995 Oct; 90(10):1771-5.
    View PubMed
  351. Saslow SB, Camilleri M. Diabetic diarrhea. Semin Gastrointest Dis 1995 Oct; 6(4):187-93.
    View PubMed
  352. Ford MJ, Camilleri MJ, Hanson RB, Wiste JA, Joyner MJ. Hyperventilation, central autonomic control, and colonic tone in humans. Gut 1995 Oct; 37(4):499-504.
    View PubMed
  353. Surrenti E, Rath DM, Pemberton JH, Camilleri M. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol 1995 Sep; 90(9):1471-5.
    View PubMed
  354. Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 1995 Sep; 109(3):755-65.
    View PubMed
  355. Camilleri M. Gastrointestinal manifestations of diabetes mellitus. (Overview). Eur J Gastroenterol Hepatol 1995 Aug; 7:709-710.
  356. Ford MJ, Camilleri M, Wiste JA, Hanson RB. Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut 1995 Aug; 37(2):264-9.
    View PubMed
  357. Singaram C, Sweet MA, Gaumnitz EA, Cameron AJ, Camilleri M. Peptidergic and nitringergic denervation in congenital esophageal stenosis. (Note). Gastroenterology 1995 Jul; 109:275-281.
    View PubMed
  358. Scolapio JS, Camilleri M, von der Ohe MR, Hanson RB. Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism. Scand J Gastroenterol 1995 Jun; 30(6):562-7.
    View PubMed
  359. Forstrom LA, Dunn WL, Rowe FA, Camilleri M. In-111-oxine-labelled granulocyte dosimetry in normal subjects. Nucl Med Commun 1995 May; 16:349-356.
    View PubMed
  360. Gaspari JC, Sande JR, Thomas CF Jr, Zighelboim J, Camilleri M. Lupus anticoagulant masquerading as an acute abdomen with multiorgan involvement. Am J Gastroenterol 1995 May; 90(5):825-6.
    View PubMed
  361. von der Ohe MR, Camilleri M, Thomforde GM, Klee GG. Differential regional effects of octreotide on human gastrointestinal motor function. Gut 1995 May; 36(5):743-8.
    View PubMed
  362. Pemberton JH, Camilleri M, Fleshman JW. Clinical management of the constipated patient. Ann Intern Med 1995 Apr 15; 122:632.
  363. O'Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology 1995 Apr; 108(4):1024-9.
    View PubMed
  364. Charles F, Camilleri M, Phillips SF, Thomforde GM, Forstrom LA. Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc 1995 Feb; 70(2):113-8.
    View PubMed
  365. Thomforde GM, Camilleri M, Phillips SF, Forstrom LA. Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med 1995 Jan; 36(1):93-6.
    View PubMed
  366. Camilleri M. The management of chronic intestinal psuedo-obstruction Motility 1995; 30:7-10.
  367. Camilleri M. Irritable bowel syndrome: the pathophysiologic links to more effective future therapy Participate Practical Gastroenterology (reprint), 1316-18, 1999 1995; 4:1-2.
  368. Camilleri M, Ford M, Bharucha A, Hanson R, Zinsmeister A. Psychosensory and autonomic modulation of colonic sensation in healthy humans. Third International Symposium on Brain-Gut Interactions Cambridge, UK, July 19-22, 1995.
  369. Low PA, Opfer-Gehrking TL, Textor SC, Schondorf R, Suarez GA, Fealey RD, Camilleri M. Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst 1994 Dec 15; 50(2):181-8.
    View PubMed
  370. Camilleri M, Prather CM. Axial forces during gastric emptying in health and models of disease. Dig Dis Sci 1994 Dec; 39(Suppl S):S14-S17.
    View PubMed
  371. Camilleri M, Thompson WG, Fleshman JW, Pemberton JH. Clinical management of intractable constipation. Ann Intern Med 1994 Oct 1; 121(7):520-8.
    View PubMed
  372. Camilleri M. Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility. Am J Gastroenterol 1994 Oct; 89(10):1769-74.
    View PubMed
  373. von der Ohe MR, Camilleri M, Carryer PW. A patient with localized megacolon and intractable constipation: evidence for impairment of colonic muscle tone. Am J Gastroenterol 1994 Oct; 89(10):1867-70.
    View PubMed
  374. Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 1994 Sep; 44(9):1675-82.
    View PubMed
  375. Vonderohe MR, Hanson RB, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil 1994 Sep; 6:213-222.
  376. Haruma K, Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut 1994 Aug; 35(8):1064-9.
    View PubMed
  377. Camilleri M, Von der Ohe MR. Drugs affecting serotonin receptors. Baillieres Clin Gastroenterol 1994 Jun; 8(2):301-19.
    View PubMed
  378. Vonderohe MR, Camilleri M, Kvols LK. A 5HT(3) antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology 1994 May; 106:1184-1189.
    View PubMed
  379. Camilleri M. Human gastroduodenojejunal manometry. Dig Dis Sci 1994 May; 39:1149-1150.
    View PubMed
  380. Camilleri M, Balm RK, Zinsmeister AR. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology 1994 Apr; 106(4):916-23.
    View PubMed
  381. Camilleri M. Small bowel motility disorders. Rev Gastroenterol Mex 1994 Apr-Jun; 59(2):120-6.
    View PubMed
  382. von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut 1994 Apr; 35(4):536-41.
    View PubMed
  383. Frank JW, Sarr MG, Camilleri M. Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: an analysis of clinical outcome. Am J Gastroenterol 1994 Mar; 89(3):339-44.
    View PubMed
  384. Camilleri M. Atlas of Gastrointestinal Motility in Health and Disease Gastroenterology ( 1994; Book review).
  385. Valdovinos MA, Camilleri M, Thomforde GM, Frie C. Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal mobility disorders. Scand J Gastroenterol 1993 Nov; 28:963-968.
    View PubMed
  386. Von Der Ohe M, Camilleri M, Zimmerman BR. Management of diabetic enteropathy. Endocrinologist 1993 Nov; 3:400-408.
  387. von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 1993 Oct 7; 329(15):1073-8.
    View PubMed
  388. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 1993 Oct; 7(5):543-51.
    View PubMed
  389. Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993 Jul; 68(7):691-702.
    View PubMed
  390. Oosterbosch L, von der Ohe M, Valdovinos MA, Kost LJ, Phillips SF, Camilleri M. Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action. Gut 1993 Jun; 34(6):794-8.
    View PubMed
  391. Aggarwal AM, Camilleri M, Phillips SF, Schlagheck TG, Brown ML, Thomforde GM. Olestra, a nondigestible, nonabsorbable fat. Effects on gastrointestinal and colonic transit. Dig Dis Sci 1993 Jun; 38(6):1009-14.
    View PubMed
  392. Badley AD, Camilleri M, O'Connor MK. Noninvasive measurement of human ascending colon volume. Nucl Med Commun 1993 Jun; 14(6):485-9.
    View PubMed
  393. Prather CM, Camilleri M, Thomforde GM, Forstrom LA, Zinsmeister AR. Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol 1993 May; 264(5 Pt 1):G928-34.
    View PubMed
  394. Camilleri M. Study of human gastroduodenojejunal motility. Dig Dis Sci 1993 May; 38:785-794.
    View PubMed
  395. Camilleri M, Balm RK, Low PA. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction. Clin Auton Res 1993 Apr; 3(2):95-100.
    View PubMed
  396. Bharucha AE, Camilleri M, Low PA, Zinsmeister AR. Autonomic dysfunction in gastrointestinal motility disorders. Gut 1993 Mar; 34(3):397-401.
    View PubMed
  397. Leighton JA, Valdovinos MA, Pemberton JH, Rath DM, Camilleri M. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum 1993 Feb; 36(2):182-5.
    View PubMed
  398. Hammer J, Camilleri M, Phillips SF, Aggarwal A, Haddad AM. Does the ileocolonic junction differentiate between solids and liquids? Gut 1993 Feb; 34(2):222-6.
    View PubMed
  399. Camilleri M. Four patients with intractable constipation. Gastrointestinal Diseases Today 1993; 2:7-15.
  400. Valdovinos MA, Thomforde GM, Camilleri M. Effect of putative carcinoid mediators on gastric acid and small bowel transit in rats and the role of 5HT receptors. Aliment Pharmacol Ther 1993; 7:61-66.
    View PubMed
  401. von der Ohe MR, Camilleri M. Measurement of small bowel and colonic transit: indications and methods. Mayo Clin Proc 1992 Dec; 67(12):1169-79.
    View PubMed
  402. Miedema BW, Kelly KA, Camilleri M, Hanson RB, Zinsmeister AR, O'Connor MK, Brown ML. Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology 1992 Oct; 103(4):1133-43.
    View PubMed
  403. Fich A, Steadman CJ, Phillips SF, Camilleri M, Brown ML, Haddad AC, Thomforde GM. Ileocolonic transit does not change after right hemicolectomy. Gastroenterology 1992 Sep; 103(3):794-9.
    View PubMed
  404. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 1992 Aug; 67(8):725-31.
    View PubMed
  405. Camilleri M, Prather CM, Evans MA, Andresen-Reid ML. Balance studies and polymeric glucose solution to optimize therapy after massive intestinal resection. Mayo Clin Proc 1992 Aug; 67(8):755-60.
    View PubMed
  406. Vassallo MJ, Camilleri M, Prather CM, Hanson RB, Thomforde GM. Measurement of axial forces during emptying from the human stomach. Am J Physiol 1992 Aug; 263(2 Pt 1):G230-9.
    View PubMed
  407. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology 1992 Jul; 103(1):36-42.
    View PubMed
  408. Camilleri M, Prather CM. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med 1992 Jun 15; 116(12 Pt 1):1001-8.
    View PubMed
  409. Ruytjens I, Thomforde GM, Camilleri M, Chapman NJ. Effect of chemical sympathectomy on scintigraphic gastric and small bowel transit in the rat. J Auton Nerv Syst 1992 Jun 15; 39(2):111-7.
    View PubMed
  410. Stark ME, Camilleri M, Fitzpatrick LA, Van Heerden JA. A 47-year-old woman with chronic constipation, hypercalcemia, and pulmonary nodule. Gastroenterology 1992 Jun; 5:115-125.
  411. Vassallo MJ, Camilleri M, Sullivan SN, Thomforde GM. Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol 1992 Apr; 14(3):255-9.
    View PubMed
  412. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut 1992 Apr; 33(4):541-6.
    View PubMed
  413. Vassallo M, Camilleri M, Phillips SF, Brown ML, Chapman NJ, Thomforde GM. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology 1992 Jan; 102(1):102-8.
    View PubMed
  414. Prather CM, Camilleri M. Medical management of small bowel motility disorders and chronic intestinal pseudo-obstruction. Pract Gastroenterol 1992; 16:25-37.
  415. Camilleri M. Targeting therapy for the irritable bowel syndrome. Med Actual 1992; 28:581-589.
  416. Layer P, Berges F-W, Camilleri M, Ihe M v d Erckenbrecht JF. Untersuchungen der motilitat und des transits Gastroenterologie Vol 10 Goebell H (ed) Innere Medizin der Gegenwart Munchen, Wien, & Schwarzenberg, , pp 186-203 1992; Baltimore:Urban.
  417. Layer P, Camilleri M. Erbrechan Gastroenterologie Vol 10 Goebell H(ed) Innere Medizine de Gegenwart Munchen, Wien, & Schwarzenberg, , pp 87-92 1992; Baltimore:Urban.
  418. Steadman CJ, Phillips SF, Camilleri M, Haddad AC, Hanson RB. Variation of muscle tone in the human colon. Gastroenterology 1991 Aug; 101(2):373-81.
    View PubMed
  419. Camilleri M, Carbone LD, Schuffler MD. Familial enteric neuropathy with pseudoobstruction. Dig Dis Sci 1991 Aug; 36(8):1168-71.
    View PubMed
  420. Stivland T, Camilleri M, Vassallo M, Proano M, Rath D, Brown ML, Thomforde G, Pemberton JH, Phillips SF. Scintigraphic measurement of regional gut transit idiopathic constipation. Gastroenterology 1991 Jul; 101:107-115.
    View PubMed
  421. Phillips SF, Camilleri M. The ileocecal area and the irritable bowel syndrome. Gastroenterol Clin North Am 1991 Jun; 20(2):297-311.
    View PubMed
  422. Camilleri M, Vassallo M. Small intestinal motility and transit in disease. Baillieres Clin Gastroenterol 1991 Jun; 5(2):431-51.
    View PubMed
  423. Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, Proano M. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci 1991 May; 36(5):609-15.
    View PubMed
  424. Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991 May; 36(5):616-20.
    View PubMed
  425. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology 1991 May; 100(5 Pt 1):1311-8.
    View PubMed
  426. Abell TL, Camilleri M, Hench VS, Malagelada JR. Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatol 1991 Feb; 3:163-167.
  427. Vassallo M, Camilleri M, Caron BL, Low PA. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology 1991 Jan; 100(1):252-8.
    View PubMed
  428. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991 Jan; 100(1):137-42.
    View PubMed
  429. Proano M, Camilleri M, Phillips SF, Thomforde GM, Brown ML, Tucker RL. The unprepared human colon does not discriminate between solids and liquids. Am J Physiol 1991; (260):G13-G16.
  430. Camilleri M. Medical treatment of chronic intestinal pseudo-obstruction. Pract Gastroenterol 1991; 15:10-22.
  431. Kim CH, Kennedy FP, Camilleri M, Zinsmeister AR, Ballard DJ. The relationship between clinical factors and gastrointestinal dysmotility in diabetes mellitus. Journal of Gastrointestinal Motility 1991; 3:268-272.
  432. Kelly DG, Camilleri M. Gastrointestinal motility. Support Line 1991; 13:7-10.
  433. Camilleri M. A guide to the treatment of GI motility disorders. Drug Therapy 1991; 21:15-28.
    View PubMed
  434. Camilleri M, Phillips SF. Acute and chronic intestinal pseudo-obstruction. Adv Intern Med 1991; 36:287-306.
    View PubMed
  435. Sandborn WJ, Camilleri M. Laboratory investigation in inflammatory bowel disease. Pract Gastroenterol 1991; 15:11-15.
  436. Thomforde GM, Malagelada JR, Camilleri M, Yaksh TL. Demonstration of intrathecal and systemic morphine and ST-91 effects on fed canine upper gut motility. Dig Dis Sci 1990 Oct; 35(10):1249-56.
    View PubMed
  437. Fich A, Neri M, Camilleri M, Kelly KA, Phillips SF. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol 1990 Oct; 12(5):505-12.
    View PubMed
  438. Greydanus MP, Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM. Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology 1990 Jul; 99(1):158-64.
    View PubMed
  439. Camilleri M. Disorders of gastrointestinal motility in neurologic diseases. Mayo Clin Proc 1990 Jun; 65(6):825-46.
    View PubMed
  440. Proano M, Camilleri M, Phillips SF, Brown ML, Thomforde GM. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol 1990 Jun; 258(6 Pt 1):G856-62.
    View PubMed
  441. Camilleri M, Fealey RD. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal diseases: a causal association? Dig Dis Sci 1990; 35:609-616.
    View PubMed
  442. Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry MC. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci 1989 Dec; 34(12):1937-42.
    View PubMed
  443. Camilleri M, Neri M. Motility disorders and stress. Dig Dis Sci 1989 Nov; 34(11):1777-86.
    View PubMed
  444. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology 1989 Sep; 97(3):775-7.
    View PubMed
  445. Fich A, Camilleri M, Phillips SF. Effect of age on human gastric and small bowel motility. J Clin Gastroenterol 1989 Aug; 11(4):416-20.
    View PubMed
  446. Barbara L, Camilleri M, Corinaldesi R, Crean GP, Heading RC, Johnson AG, Malagelada JR, Stanghellini V, Wienbeck M. Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci 1989 Aug; 34(8):1272-6.
    View PubMed
  447. Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM, Chapman N, Zinsmeister AR. Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol 1989 Aug; 257(2 Pt 1):G284-90.
    View PubMed
  448. Camilleri M, Proano M. Advances in the assessment of disease activity in inflammatory bowel disease. Mayo Clin Proc 1989 Jul; 64(7):800-7.
    View PubMed
  449. Camilleri M, Phillips SF. Disorders of small intestinal motility. Gastroenterol Clin North Am 1989 Jun; 18(2):405-24.
    View PubMed
  450. Camilleri M. Jejunal manometry in distal subacute mechanical obstruction: significance of prolonged simultaneous contractions. Gut 1989 Apr; 30(4):468-75.
    View PubMed
  451. Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AR. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989 Mar; 96(3):704-12.
    View PubMed
  452. Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989 Jan; 96(1):110-5.
    View PubMed
  453. Colemont LJ, Camilleri M. Subspecialty clinics: gastroenterology. Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc 1989 Jan; 64:60-70.
    View PubMed
  454. Camilleri M. Chronic intestinal pseudo-obstruction: new approaches in diagnosis and treatment. Investigation and Treatment of Upper Gastrointestinal Motility Disorders Proceedings of a symposium held in Ottawa, Canada Publishing Foundation, , pp 19-26 1988; Toronto:The Medicine.
  455. Abell TL, Malagelada JR, Lucas AR, Brown ML, Camilleri M, Go VL, Azpiroz F, Callaway CW, Kao PC, Zinsmeister AR. Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology 1987 Nov; 93(5):958-65.
    View PubMed
  456. Shetty N, Camilleri M, Moss DW, Hodgson HJ. Subtle hyperthyroidism presenting as suspected hepatobiliary disease. J Clin Gastroenterol 1987 Apr; 9(2):186-8.
    View PubMed
  457. Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987 Jan; 28(1):5-12.
    View PubMed
  458. Camilleri M. Clinical gastroenterology in Malta. Malta: Printex Publishers; 1987.
  459. Vassallo M, Camilleri M. Monoclonal protein amyloidosis presenting with hepatomegaly Clinical Gastroenterology in Malta Camiller M ed Publishers Printex Malta, , pp77-81 1987.
  460. Camilleri M. AIDS diagnosis and control: report on the current situation in Malta, March 1987. AIDS Diagnosis and Report of a WHO meeting held in Munich March 16-18, Koch MA, Deinhardt F, eds Munich MMV Medizin Verlag, 1988, pp 139-140 1987; Control:Current Situation.
  461. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci 1986 Nov; 31:1169-1177.
    View PubMed
  462. Camilleri M, Brown ML, Malagelada JR. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology 1986 Sep; 91(3):619-26.
    View PubMed
  463. Camilleri M, Thompson DG, Malagelada JR. Functional dyspepsia. Symptoms and underlying mechanism. J Clin Gastroenterol 1986 Aug; 8(4):424-9.
    View PubMed
  464. Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986 Jul; 91(1):94-9.
    View PubMed
  465. Camilleri M, Malagelada JR, Stanghellini V, Zinsmeister AR, Kao PC, Li CH. Dose-related effects of synthetic human beta-endorphin and naloxone on fed gastrointestinal motility. Am J Physiol 1986 Jul; 251(1 Pt 1):G147-54.
    View PubMed
  466. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986 Jun; 90(6):1919-25.
    View PubMed
  467. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 1986 May; 90(5 Pt 1):1121-8.
    View PubMed
  468. Camilleri M, Mearin F. Evaluation of gastric motility disorders by gastrointestinal manometry and radioscintigraphic gastric emptying studies. Gastrum 1986 Apr; 34-40.
  469. Mearin F, Camilleri M. Diabetic gastroparesis. Gastrum 1986 Apr; 40-5.
  470. Camilleri M. Alimentary tract and pancreas. New approaches to the diagnosis of functional upper gut disease. J Gastroenterol Hepatol 1986; 1:273-279.
  471. Wood JR, Camilleri M, Low PA, Malagelada JR. Brainstem tumor presenting as an upper gut motility disorder. Gastroenterology 1985 Dec; 89(6):1411-4.
    View PubMed
  472. Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 1985 Nov; 249(5 Pt 1):G580-5.
    View PubMed
  473. Camilleri M, Malagelada JR, Stanghellini V, Fealey RD, Sheps SG. Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology 1985 Jun; 88(6):1852-9.
    View PubMed
  474. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984 Dec; 14(6):420-7.
    View PubMed
  475. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Effect of somatovisceral reflexes and selective dermatomal stimulation on postcibal antral pressure activity. Am J Physiol 1984 Dec; 247(6 Pt 1):G703-8.
    View PubMed
  476. Malagelada JR, Camilleri M. Unexplained vomiting: a diagnostic challenge. Ann Intern Med 1984 Aug; 101(2):211-8.
    View PubMed
  477. Camilleri M, Chadwick VS, Hodgson HJ. Vascular anomalies of the gastrointestinal tract. Hepatogastroenterology 1984 Jun; 31(3):149-53.
    View PubMed
  478. Camilleri M, Victorino RM, Hodgson HJ. Halothane aggravation of chronic liver disease. Acta Med Port 1984 Jun; 5(6):194-6.
    View PubMed
  479. Cox TM, O'Donnell MW, Camilleri M. Allelic heterogeneity in adult hereditary fructose intolerance. Detection of structural mutations in the aldolase B molecule. Mol Biol Med 1983 Nov; 1(4):393-400.
    View PubMed
  480. Camilleri M, Krausz T, Lewis PD, Hodgson HJ, Pallis CA, Chadwick VS. Malignant histiocytosis and encephalomyeloradiculopathy complicating coeliac disease. Gut 1983 May; 24(5):441-7.
    View PubMed
  481. Camilleri M, Pusey CD, Chadwick VS, Rees AJ. Gastrointestinal manifestations of systemic vasculitis. Q J Med 1983 Spring; 52(206):141-9.
    View PubMed
  482. Cox TM, O'Donnell MW, Sochor M, Camilleri M, McLean P. Hereditary fructose intolerance: presence of a potent inhibitor of fructose-1-phosphate aldolase in the liver. Biochem Soc Trans 1983; 11:202-203.
  483. Cox TM, O'Donnell MW, Camilleri M, Burghes A. Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. J Clin Invest 1983; 72:201-213.
    View PubMed
  484. Maton PN, Camilleri M, Griffin GE, Allison DJ, Hodgson HJF, Chadwick VS. Role of hepatic artery embolization in the carcinoid syndrome. Br Med J 1983; 287:932-934.
  485. Camilleri M, Satti MB, Wood CB. Cystic lymphangioma of the colon. Endoscopic and histologic features. Diseases of the Colon & Rectum 1982 Nov-Dec; 25(8):813-6.
    View PubMed
  486. Camilleri M, Hemingway AP, Chadwick VS, Blumgart LH, Hodgson HJ, Allison DJ. Embolization of an intrapancreatic aneurysm. Br J Radiol 1982 Sep; 55(657):685-7.
    View PubMed
  487. Cox TM, Camilleri M, O'Donnell MW, Chadwick VS. Pseudodominant transmission of fructose intolerance in an adult and three offspring: Heterozygote detection by intestinal biopsy. N Engl J Med 1982 Aug 26; 307(9):537-40.
    View PubMed
  488. Camilleri M, Murphy R, Chadwick VS. Pharmacological inhibition of chenodeoxycholic acid-induced secretion of fluid and mucus in the rabbit colon. Dig Dis Sci 1982; 27:865-869.
    View PubMed
  489. Camilleri M, Schafler K, Chadwick VS, Hodgson HJ, Weinbren K. Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology 1981 Apr; 80(4):810-5.
    View PubMed
  490. Chadwick VS, Camilleri M. Role of bile acids in the pathogenesis of diarrhea in various diseases. Acta Gastroenterol Belg 1981; 44:43-48.
    View PubMed
  491. Camilleri M, Cooper BT, Adrian T, Bloom SR, Chadwick VS. Effects of vasoactive intestinal polypeptide and pancreatic polypeptide in the rabbit intestine. Gut 1981; 22:14-18.
    View PubMed
  492. Camilleri M, Murphy R, Chadwick VS. Dose-related effects of chenodeoxycholic acid in the rabbit colon. Dig Dis Sci 1980 Jun; 25(6):433-8.
    View PubMed
  493. Camilleri M, Fenech FF. Thrombophlebitis migrans in ulcerative colitis. Postgrad Med J 1977; 52:762-763.
  494. Camilleri M. Anatomy of the newborn child. Chest-Piece (Malta) 1972 Dec.


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.